Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-04-21 | 2022-04-13 |
| Drug Identification Number | 00544884 | 00544884 |
| Brand name | CODEINE PHOSPHATE INJECTION USP | CODEINE PHOSPHATE INJECTION USP |
| Common or Proper name | CODEINE PHOSPHATE | CODEINE PHOSPHATE |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | CODEINE PHOSPHATE | CODEINE PHOSPHATE |
| Strength(s) | 30MG | 30MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
| Packaging size | 1ML 10LIAM | 1ML 10LIAM |
| ATC code | R05DA | R05DA |
| ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-04-12 | 2022-04-12 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2022-04-20 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Discontinued | |
| Health Canada comments |